Analyst Consensus ?
ConsensusHold37 ratings
Bullish1951.4%
Neutral1745.9%
Bearish12.7%
FN2 Earnings Intelligence
Norwegian Cruise Line Holdings Ltd. (NCLH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 15, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Wells Fargo | Overweight | Overweight | Maintain | Sep 4, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 18, 2026 |
| Mizuho | Neutral | Outperform | Downgrade | Aug 18, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 31, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 31, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 31, 2026 |
| Truist Securities | Hold | Buy | Downgrade | Jul 23, 2026 |
| Jefferies | Hold | Hold | Maintain | Jul 17, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 14, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| TD Cowen | Buy | Buy | Maintain | Jun 23, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | May 5, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Apr 27, 2026 |
| Tigress Financial | Strong Buy | Strong Buy | Maintain | Apr 17, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Mar 3, 2026 |
| Macquarie | Outperform | Outperform | Maintain | May 9, 2025 |
| Loop Capital | Buy | Buy | Maintain | May 1, 2025 |
| Argus Research | Buy | Hold | Upgrade | Nov 4, 2024 |
| Deutsche Bank | Hold | Hold | Maintain | Nov 1, 2024 |
| Redburn Partners | Buy | Neutral | Upgrade | Sep 14, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | May 2, 2023 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Jun 16, 2021 |
| Berenberg | Hold | Buy | Downgrade | Feb 12, 2021 |
| SunTrust Robinson Humphrey | Hold | Buy | Downgrade | Jul 14, 2020 |
| Redburn | Neutral | Buy | Downgrade | Jun 22, 2020 |
| Nomura | Buy | Buy | Maintain | Apr 8, 2020 |
| CFRA | Sell | Strong Sell | Maintain | Mar 2, 2020 |
| Wedbush | Outperform | Outperform | Maintain | Feb 21, 2020 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 21, 2020 |
| Buckingham Research | Buy | Buy | Maintain | Nov 8, 2019 |
| Buckingham | Buy | Buy | Maintain | Nov 8, 2019 |
| Bank of America | Buy | Buy | Maintain | Aug 9, 2019 |
| Bernstein | Outperform | Market Perform | Upgrade | Jan 8, 2019 |
| Argus | Buy | Buy | Maintain | Oct 25, 2017 |
| Sterne Agee CRT | Buy | Buy | Maintain | Jun 7, 2016 |
| DNB Markets | Hold | Buy | Downgrade | Dec 18, 2014 |
| Longbow Research | Neutral | Buy | Downgrade | Jun 4, 2014 |
Upside is calculated against the persisted current price $14.72. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Canaccord Genuity | Joseph Vafi | $45 | $18.18 | +205.7% | Aug 18, 2026 |
| UBS | Analyst unavailable | $20 | $18.18 | +35.9% | Aug 18, 2026 |
| Mizuho Securities | Ben Chaiken | $17 | $18.18 | +15.5% | Aug 18, 2026 |
| Susquehanna | Analyst unavailable | $17 | $19.82 | +15.5% | Aug 4, 2026 |
| Deutsche Bank | Analyst unavailable | $17 | $18.47 | +15.5% | Jul 31, 2026 |
| Mizuho Securities | Analyst unavailable | $22 | $18.72 | +49.5% | Jul 31, 2026 |
| Barclays | Analyst unavailable | $18 | $18.72 | +22.3% | Jul 31, 2026 |
| Jefferies | Analyst unavailable | $18 | $19.61 | +22.3% | Jul 17, 2026 |
| Goldman Sachs | Lizzie Dove | $16 | $19.63 | +8.7% | Jul 14, 2026 |
| Morgan Stanley | Analyst unavailable | $22 | $19.14 | +49.5% | Jul 9, 2026 |
| BMO Capital | Tristan Thomas-Martin | $21 | $18.83 | +42.7% | Jul 7, 2026 |
| Wells Fargo | Analyst unavailable | $25 | $21.11 | +69.8% | Jul 1, 2026 |
| Bernstein | Richard Clarke | $18 | $18.13 | +22.3% | Jun 3, 2026 |
| Loop Capital Markets | Analyst unavailable | $22 | $18.34 | +49.5% | Jun 1, 2026 |
| UBS | Robin Farley | $17 | $14.94 | +15.5% | May 19, 2026 |
| Deutsche Bank | Analyst unavailable | $18 | $17.34 | +22.3% | May 5, 2026 |
| Susquehanna | Analyst unavailable | $15 | $17.2 | +1.9% | May 5, 2026 |
| Morgan Stanley | Analyst unavailable | $20 | $17.2 | +35.9% | May 5, 2026 |
| Goldman Sachs | Analyst unavailable | $14 | $17.2 | -4.9% | May 5, 2026 |
| Barclays | Analyst unavailable | $19 | $17.2 | +29.1% | May 5, 2026 |
| Wells Fargo | Analyst unavailable | $26 | $21.09 | +76.6% | Apr 15, 2026 |
| Barclays | Analyst unavailable | $21 | $19.76 | +42.7% | Apr 10, 2026 |
| Morgan Stanley | Stephen Grambling | $23 | $19.96 | +56.3% | Apr 9, 2026 |
| Mizuho Securities | Analyst unavailable | $27 | $20.16 | +83.4% | Apr 8, 2026 |
| Wolfe Research | Greg Badishkanian | $25 | $22.18 | +69.8% | Mar 3, 2026 |
| Stifel Nicolaus | Steven Wieczynski | $30 | $22.18 | +103.8% | Mar 3, 2026 |
| Morgan Stanley | Stephen Grambling | $25 | $22.18 | +69.8% | Mar 3, 2026 |
| Needham | Analyst unavailable | $27 | $22.18 | +83.4% | Mar 3, 2026 |
| Goldman Sachs | Lizzie Dove | $20 | $22.18 | +35.9% | Mar 3, 2026 |
| Mizuho Securities | Ben Chaiken | $28 | $22.18 | +90.2% | Mar 2, 2026 |
| Stifel Nicolaus | Steven Wieczynski | $31 | $23.56 | +110.6% | Feb 11, 2026 |
| Wells Fargo | Analyst unavailable | $33 | $24.34 | +124.2% | Jan 13, 2026 |
| Barclays | Analyst unavailable | $23 | $21.54 | +56.3% | Dec 17, 2025 |
| Jefferies | Analyst unavailable | $20 | $20.86 | +35.9% | Dec 15, 2025 |
| Mizuho Securities | Analyst unavailable | $32 | $20.56 | +117.4% | Dec 12, 2025 |
| Goldman Sachs | Analyst unavailable | $21 | $19.11 | +42.7% | Dec 9, 2025 |
| Truist Financial | Analyst unavailable | $26 | $18.57 | +76.6% | Dec 2, 2025 |
| Susquehanna | Christopher Stathoulopoulos | $21 | $18.82 | +42.7% | Nov 12, 2025 |
| Goldman Sachs | Analyst unavailable | $27 | $18.4 | +83.4% | Nov 5, 2025 |
| Barclays | Brandt Montour | $28 | $18.79 | +90.2% | Nov 5, 2025 |
| Truist Financial | Patrick Scholes | $31 | $25.41 | +110.6% | Sep 19, 2025 |
| Tigress Financial | Ivan Feinseth | $38 | $24.74 | +158.2% | Aug 27, 2025 |
| UBS | Analyst unavailable | $27 | $24.45 | +83.4% | Aug 26, 2025 |
| Goldman Sachs | Lizzie Dove | $34 | $26.42 | +131.0% | Jan 23, 2025 |
| Truist Financial | Patrick Scholes | $35 | $28.4 | +137.8% | Dec 2, 2024 |
| Tigress Financial | Ivan Feinseth | $36 | $27.82 | +144.6% | Nov 11, 2024 |
| Macquarie | Paul Golding | $30 | $24.88 | +103.8% | Nov 1, 2024 |
| Morgan Stanley | Stephen Grambling | $19 | $23.96 | +29.1% | Oct 30, 2024 |
| Barclays | Brandt Montour | $26 | $23.71 | +76.6% | Oct 22, 2024 |
| Citigroup | James Hardiman | $30 | $23.07 | +103.8% | Oct 9, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $29 | $20.39 | +97.0% | Oct 4, 2024 |
| Mizuho Securities | Ben Chaiken | $26 | $17.94 | +76.6% | Sep 11, 2024 |
| Truist Financial | Patrick Scholes | $21 | $16.56 | +42.7% | May 29, 2024 |
| Mizuho Securities | Ben Chaiken | $24 | $16 | +63.0% | May 28, 2024 |
| Deutsche Bank | Chris Woronka | $20 | $16.94 | +35.9% | May 21, 2024 |
| Barclays | Brandt Montour | $20 | $16.94 | +35.9% | May 21, 2024 |
| UBS | Robin Farley | $19 | $16.94 | +29.1% | May 21, 2024 |
| Wells Fargo | Daniel Politzer | $20 | $16.94 | +35.9% | May 21, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $26 | $16.94 | +76.6% | May 21, 2024 |
| Wells Fargo | Daniel Politzer | $19 | $16.08 | +29.1% | May 2, 2024 |
| Stifel Nicolaus | Steven Wieczynski | $25 | $19.17 | +69.8% | Apr 9, 2024 |
| Mizuho Securities | Ben Chaiken | $21 | $20.54 | +42.7% | Mar 25, 2024 |
| Goldman Sachs | Lizzie Dove | $19 | $19.87 | +29.1% | Mar 13, 2024 |
| Redburn Partners | Alex Brignall | $25 | $15.18 | +69.8% | Sep 25, 2023 |
| Morgan Stanley | Analyst unavailable | $11.5 | $13.75 | -21.9% | Jan 10, 2023 |
| UBS | Analyst unavailable | $13 | $13.8 | -11.7% | Jan 9, 2023 |
| UBS | Analyst unavailable | $19 | $15.46 | +29.1% | Dec 13, 2022 |
| J.P. Morgan | Analyst unavailable | $30 | $15.64 | +103.8% | Dec 6, 2022 |
| Truist Financial | Analyst unavailable | $21 | $16.12 | +42.7% | Nov 22, 2022 |
| Credit Suisse | Analyst unavailable | $14 | $17.59 | -4.9% | Nov 17, 2022 |
| UBS | Analyst unavailable | $24 | $17.87 | +63.0% | Nov 14, 2022 |
| Tigress Financial | Ivan Feinseth | $32 | $14.62 | +117.4% | Oct 21, 2022 |
| Morgan Stanley | Thomas Allen | $13 | $14.16 | -11.7% | Aug 12, 2022 |
| Morgan Stanley | Thomas Allen | $14 | $11.43 | -4.9% | Jun 20, 2022 |
| Susquehanna | Christopher Stathoulopoulos | $20 | $11.43 | +35.9% | Jun 18, 2022 |
| Morgan Stanley | Thomas Allen | $18 | $16.14 | +22.3% | May 13, 2022 |
| Citigroup | Analyst unavailable | $24 | $22.22 | +63.0% | Apr 19, 2022 |
| Truist Financial | Patrick Scholes | $20 | $19.86 | +35.9% | Mar 25, 2022 |
| Macquarie | Paul Golding | $23 | $17.39 | +56.3% | Mar 4, 2022 |
| Citigroup | James Ainley | $25 | $22.63 | +69.8% | Feb 10, 2022 |
| J.P. Morgan | Brandt Montour | $37 | $24.66 | +151.4% | Aug 9, 2021 |
| UBS | Robin M. Farley | $29 | $27.66 | +97.0% | May 11, 2021 |
| Goldman Sachs | Stephen Grambling | $37 | $26.75 | +151.4% | Apr 20, 2021 |
Track every rating change on NCLH the moment it posts. Free to start.
Start free